“Accelerating the Next Generation of Immune Medicine with Cellular Proteomics at The University of Florida”

Join our webinar to discuss IsoPlexis’ product suite capabilities and how functional phenotyping is addressing urgent challenges central to unlocking the next stage of personalized cancer immunotherapies and vaccines related to immunological mechanisms in infectious disease. With single-cell proteomics barcoding and detection of a full range of cytokines (30+) per single-cell across  thousands of single-cells, the IsoLight platform is showing the unique value of resolving the heterogeneity of a variety of immune cell types, elucidating key pre-clinical translational biomarkers to accelerate research and discovery.

TOPICS INCLUDE:

• Reveal the functional mechanism of immune activation in a novel agonist combination with adoptive cell therapy
• Uncover the role of TILs within Ipi/Nivo checkpoint combination and reveal the biological drivers of patient response
• Identify the unique polyfunctional monocyte cell types that drive tumor suppression
• Understand the functional differences of tumor antigen potency in bispecifics
• Identify functional immune mechanism CD8 T cell response for infectious diseases
• And other single-cell functional proteomics cases

For more information contact:

• Luke Harrison, Isoplexis Sales Specialist [luke.harrison@isoplexis.com]

• Dr. Angel Sampson, ICBR Monoclonal Antibody Scientific Director [angel.sampson@ufl.edu]